Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Adefovir Dipivoxil with Tacrolimus or Cyclosporine in Post-Liver Transplant
NCT00644761Phase 2Completed
- Sponsor
- Gilead Sciences
- Start
- Feb 2004
- Primary completion
- May 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of adefovir dipivoxil in hepatitis B (HBV), sponsored by Gilead Sciences. Primary endpoint: Pharmacokinetics of Tacrolimus or Cyclosporine at 21 days. Started Feb 2004; status: completed.
02
Drugs
adefovir dipivoxil
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT00644761.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00644761.